Literature DB >> 6150321

Beneficial effects of plasma exchange in acute inflammatory polyradiculoneuropathy.

P O Osterman, J Fagius, G Lundemo, P Pihlstedt, R Pirskanen, A Sidén, J Säfwenberg.   

Abstract

The results of a controlled trial in which 38 patients with severe acute inflammatory polyradiculoneuropathy took part indicate that plasma exchange favourably influenced the course of the disease. Significant benefits were seen in time until onset of improvement, course of muscular weakness, improvement in disability grades over the first 2 months, and working capacity after 1 month. Cost-benefit analysis showed that the exchange treatment resulted in net financial savings. The results suggest that plasma exchange may have a role in the treatment of severe acute inflammatory polyradiculoneuropathy.

Entities:  

Mesh:

Year:  1984        PMID: 6150321     DOI: 10.1016/s0140-6736(84)90819-5

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  31 in total

Review 1.  Intravenous immunoglobulin treatment in neurological diseases.

Authors:  A Otten; M Vermeulen; P M Bossuyt; A Otten
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-04       Impact factor: 10.154

Review 2.  Guillain-Barré syndrome: a century of progress.

Authors:  John A Goodfellow; Hugh J Willison
Journal:  Nat Rev Neurol       Date:  2016-11-18       Impact factor: 42.937

Review 3.  Immunotherapy of Guillain-Barré syndrome.

Authors:  Shuang Liu; Chaoling Dong; Eroboghene Ekamereno Ubogu
Journal:  Hum Vaccin Immunother       Date:  2018-07-12       Impact factor: 3.452

4.  IgG immunoadsorption in experimental allergic neuritis: effect on antibody levels and clinical course.

Authors:  G K Harvey; K Schindhelm; J D Pollard
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-07       Impact factor: 10.154

5.  Occurrence, clinical manifestations, and prognosis of Guillain-Barré syndrome.

Authors:  H Rantala; M Uhari; M Niemelä
Journal:  Arch Dis Child       Date:  1991-06       Impact factor: 3.791

6.  Plasma exchange for Guillain-Barré syndrome.

Authors:  R A Hughes
Journal:  Br Med J (Clin Res Ed)       Date:  1985-09-07

7.  The treatment of Guillain-Barré syndrome by modified plasma exchange--a cost effective method for developing countries.

Authors:  H J De Silva; R Gamage; H K Herath; M G Karunanayake; J B Peiris
Journal:  Postgrad Med J       Date:  1987-12       Impact factor: 2.401

8.  Guillain-Barré syndrome: the evolution of therapy.

Authors:  D R Cornblath; R A Hughes
Journal:  J Neurol       Date:  1994-05       Impact factor: 4.849

Review 9.  Plasma exchange for Guillain-Barré syndrome.

Authors:  Sylvie Chevret; Richard Ac Hughes; Djillali Annane
Journal:  Cochrane Database Syst Rev       Date:  2017-02-27

10.  Tumour necrosis factor-alpha and other cytokines in Guillain-Barré syndrome.

Authors:  A R Exley; N Smith; J B Winer
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-09       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.